FDA pharmacologic class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor
3 medicines are in FDA's class of cytomegalovirus nucleoside analog dna polymerase inhibitors: valganciclovir (Valcyte), ganciclovir (Zirgan) and cidofovir. All 3 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is valganciclovir 450 mg tablet at $1.91 per tablet (NADAC).
Which medicines are cytomegalovirus nucleoside analog dna polymerase inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Valganciclovir | Valcyte | 19 labelers | $1.91 per tablet 450 mg tablet | Yes | No current entry | 2 |
| Ganciclovir | Zirgan | 6 labelers | $91.24 per gram 0.15% ophthalmic gel | Yes | No current entry | 2 |
| Cidofovir | none listed | 2 labelers | n/a | Yes | No current entry | 2 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price